Testing effectiveness (Phase 2)Study completedNCT02181634
What this trial is testing
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Who this might be right for
Cholangiocarcinoma
PrECOG, LLC. 74